The results also in the CGGA revealed that the glioblastoma patients receiving chemotherapy or radiotherapy in the high LMO1 expression group had a poorer prognosis than patients in the low LMO1 expression group (Figures 2G, H). This evidence concerns the gene LMO1 and glioblastoma.